VAERS Datenanalyse und Statistik
Zurueck zur Suche

Reporte zur Charge UT8076NA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NC 7 KS 1 IA 1 TX 1

VAERS 2690005

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

schwer
Staat
NC
Alter
37,0
Geschlecht
F
Eingang
03.10.2023
Impfdatum
28.09.2023
Beginn
28.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction Dysphonia Erythema Throat tightness

Symptomtext

Anaphylaxis - Throat closing, hoarseness, arm redness Went to ED was given IV Benadryl, IV steroid and IV pepcid. Given prescription for EPI PEN

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Folic Acid 400mcg daily
Allergien
Kiwi, Amoxicillin and Bactrim
Vorherige Impfungen
-

VAERS 2701258

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

moderat
Staat
NC
Alter
27,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
03.10.2023
Beginn
01.10.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Pain

Symptomtext

experiencing prolonged arm pain at injection site post administration; complained of difficulty lifting her arm because of the pain; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 27 years old female patient who had prolonged arm pain at injection site post administration and complained of difficulty lifting her arm because of the pain after receiving influenza quadrival A-B vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. List concomitant or other vaccines: NO On 03-Oct-2023, the patient received a standard dose of suspect influenza quadrival A-B vaccine Suspension for injection at a dose of 0.5 ml total (lot UT8076NA, expiry date- 30-JUN-2024) via intramuscular route in the right deltoid for Immunization. On an unknown date in OCT-2023, (unknown latency), the patient developed prolonged arm pain at injection site post administration (vaccination site pain) and complained of difficulty lifting her arm because of the pain (injected limb mobility decreased) following the administration of influenza quadrival A-B vaccine. Action taken was not applicable. Treatment: Patient went to Urgent Care last week, prescribed steroids At time of reporting, the outcome was Not Recovered / Not Resolved for both the events.; Sender's Comments: US-SA-2023SA322148:Patient #2: US-SA-2023SA322445:Patient #4:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2723025

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

mild
Staat
NC
Alter
27,0
Geschlecht
F
Eingang
11.12.2023
Impfdatum
07.12.2023
Beginn
07.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Epistaxis Injection site nodule Injection site pruritus Injection site swelling Pruritus Respiratory tract congestion

Symptomtext

Starting 12/7 at 10am my arm began itching. On 12/8 my arm was itching, there was a knot at the injection site, and I began to feel congested- later that evening around 5pm, I began to have a nosebleed. On 12/9 I had itching/swelling at injection site plus more congestion. 12/10 I was the same as 12/9. 12/11, I have been congested, nosebleed, small knot and itching at injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site nodule
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Nov-13 HUB
Vorgeschichte
Nursing 3 month old infant Asthma, GERD
Andere Medikamente
Prenatal and lactation supplement, omperazole
Allergien
walnuts and minocycline
Vorherige Impfungen
-

VAERS 2705288

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

mild
Staat
NC
Alter
28,0
Geschlecht
F
Eingang
28.10.2023
Impfdatum
03.10.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

ongoing arm pain post administration; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from a physician. This case is linked to cases 0180811(CLUSTER), 01808146 (CLUSTER) and 01808177(CLUSTER). This case involves a 28 years old female patient who experienced ongoing arm pain post administration after receiving Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-Oct-2023, the patient received 0.5 ml of suspect Influenza Quadrival A-B Vaccine Suspension for injection (lot number:UT8076NA) (Expiry date: 30-Jun-2024) (with an unknown strength) via intramuscular route in the left deltoid for immunization. On an unknown date, the patient developed event of ongoing arm pain post administration (pain in extremity) (unknown latency). It was reported, Caller reporting 4 of their employees have experienced reactions after receiving FLUZONE QIV PFS, administered at their clinic as part of employee health. Caller reporting 3 patients have complained of ongoing arm discomfort and one patient experienced redness around the injection site. Caller reporting, she is concerned about continuing to use this batch of vaccines, she reports they have given over 70 FLUZONE QIV PFS and 4 have experienced reactions. Caller did not have any information as far as time frame of onset of symptoms. Percentage of Solicited Injection-site and Systemic Adverse Reactions Within 3 Days After Vaccination in Adults 18 Years of Age and Older, including Grade 2 and Grade 3 injection site pain. 3: Injection site adverse reactions: redness/erythema. Caller also with question on whether we have any information we can send as administration guide as a reference for administration.Caller reporting patient is experiencing ongoing arm pain post administration. Caller does not have details on onset of symptoms, caller has not assessed whether patient is having any difficulty lifting her arm Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. Outcome: Not Recovered / Not Resolved for the event; Sender's Comments: US-SA-2023SA322206: US-SA-2023SA322148:01808146 01808146:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2703554

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

mild
Staat
NC
Alter
64,0
Geschlecht
F
Eingang
27.10.2023
Impfdatum
03.10.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Limb discomfort Pain

Symptomtext

arm discomfort, difficulty lifting her arm because of the pain; redness around the injection site; prolonged arm pain at injection site post administration; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 64 years old female patient who experienced arm discomfort, difficulty lifting her arm because of the pain, redness around the injection site and prolonged arm pain at injection site post administration after receiving vaccine Influenza Quadrival A-B Vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-Oct-2023, the patient received 0.5 ml dose (frequency: once; strength: standard) of suspect Influenza Quadrival A-B vaccine Suspension for injection of lot UT8076NA and expiry: Jun-2024 via intramuscular route in the right deltoid for immunization. On an unknown date, the patient developed arm discomfort, difficulty lifting her arm because of the pain (limb discomfort), redness around the injection site (vaccination site erythema) and prolonged arm pain at injection site post administration (vaccination site pain) (unknown latency) following the administration of Influenza Quadrival A-B vaccine. No lab data was reported. Action taken was not applicable. It was not reported if the patient received a corrective treatment for all events. At time of reporting, the outcome was Not Recovered / Not Resolved for all events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2701257

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

mild
Staat
NC
Alter
51,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
26.09.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Rash erythematous Rash papular Rash pruritic

Symptomtext

small pinpoint, raised, itchy red bumps; small pinpoint, raised, itchy red bumps; redness at the site post injection; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 51 years old female patient who experienced small pinpoint, raised, itchy red bumps, and redness at the site post injection after receiving Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Sep-2023, the patient received 0.5 ml of suspect Influenza Quadrival A-B Vaccine Suspension for injection (lot number: UT8076NA) (Expiry date: 30-Jun-2024) (Strength: Standard) (Frequency: once) via intramuscular route in the right deltoid for immunization. On an unknown date, the patient developed small pinpoint, raised, itchy red bumps (rash papular) (rash pruritic) and redness at the site post injection (vaccination site erythema) (unknown latency). It was reported, Caller reporting 4 of their employees have experienced reactions after receiving FLUZONE QIV PFS, administered at their clinic as part of employee health. Caller reporting 3 patients have complained of ongoing arm discomfort and one patient experienced redness around the injection site. Caller reporting, she is concerned about continuing to use this batch of vaccines, she reports they have given over 70 FLUZONE QIV PFS and 4 have experienced reactions. Caller did not have any information as far as time frame of onset of symptoms. Caller also with question on whether we have any information we can send as administration guide as a reference for administration. Caller reports redness at the site post injection, unknown as far as time of onset, she thinks the following day after injection. Caller reports employee (patient) experienced small pinpoint, raised, itchy red bumps. Caller reports area is improving, no longer itchy and most of the red bumps have resolved on their own, patient does have a few small red bumps. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Recovering / Resolving for the events; Sender's Comments: US-SA-2023SA322206:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2691418

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

mild
Staat
KS
Alter
10,0
Geschlecht
M
Eingang
05.10.2023
Impfdatum
05.10.2023
Beginn
05.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Feeling hot Hyperhidrosis Pallor Vomiting

Symptomtext

Administered with no reports of concern or symptoms at 0945 on 10/5/2023. Sent back to class. Per school nurse, child became sweaty, pale, felt hot, dizzy and vomited at approximately 1030 on 10/5/2023 and she sent him home. She did not obtain vital signs prior to sending home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2684704

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

gering
Staat
IA
Alter
13,0
Geschlecht
F
Eingang
21.09.2023
Impfdatum
21.09.2023
Beginn
21.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Patient was scheduled to receive 3 vaccines, one of which was the Meningitis conjugate (Menquadfi) vaccine, but Meningitis B (Trumenba) vaccine was given in error. Meningitis conjugate was then given once error was identified. Patient tolerated all vaccines well and there were no side effects observed within 15 minutes of receiving all 4 vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
Not indicated. Patient's grandmother informed of incident and told to watch for any adverse affects and notify our office immediately if they occur.
Aktuelle Erkrankungen
None
Vorgeschichte
Egg Allergy, Still's murmur
Andere Medikamente
None
Allergien
Eggs
Vorherige Impfungen
-

VAERS 2683988

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge UT8076NA

gering
Staat
TX
Alter
13,0
Geschlecht
M
Eingang
20.09.2023
Impfdatum
19.09.2023
Beginn
19.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

PATIENT RECEIVED MENQUADFI VACCINE IN ERROR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682573

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076NA

gering
Staat
NC
Alter
12,0
Geschlecht
M
Eingang
15.09.2023
Impfdatum
15.09.2023
Beginn
15.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Zyrtec
Allergien
NKA,
Vorherige Impfungen
-